This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Earnings Preview: Bed Bath & Beyond (BBBY) Q1 Earnings Expected to Decline
by Zacks Equity Research
Bed Bath & Beyond (BBBY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bed Bath & Beyond's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Bed Bath & Beyond.
Is Bed Bath & Beyond (BBBY) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Company News for Jun 23, 2020
by Zacks Equity Research
Companies In The News Are: AAL, TSN, SPCE, BBBY.
Implied Volatility Surging for Bed Bath & Beyond (BBBY) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Bed Bath & Beyond (BBBY) stock based on the movements in the options market lately.
Ulta Beauty Online Sales, Loyalty Program Aid Amid High Costs
by Zacks Equity Research
Ulta Beauty (ULTA) has been gaining from robust online operations amid the pandemic-led store closures. However, SG&A costs have been high.
The Zacks Analyst Blog Highlights: Bed Bath & Beyond, Nordstrom, Designer Brands and Oracle
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Bed Bath & Beyond, Nordstrom, Designer Brands and Oracle
Bullish Momentum, More Good News for Markets
by Mark Vickery
Better-than-expected economic data, mixed with progress on the coronavirus treatment story, with the Fed clearing a path toward accommodative lending and plenty of liquidity have led to positive results.
Bed Bath & Beyond (BBBY) Catches Eye: Stock Jumps 6.8%
by Zacks Equity Research
Bed Bath & Beyond (BBBY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Bed Bath & Beyond (BBBY) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Bed Bath & Beyond (BBBY) closed at $7.55, marking a +0.67% move from the previous day.
Bed Bath & Beyond (BBBY) Flat As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Bed Bath & Beyond (BBBY) closed at $5.95, marking no change from the previous day.
Are Options Traders Betting on a Big Move in Bed Bath & Beyond (BBBY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Bed Bath & Beyond (BBBY) stock based on the movements in the options market lately.
Columbia Sportswear Reopens Stores, Brings Back Employees
by Zacks Equity Research
A total of 31 Columbia Sportswear (COLM) outlets will be operational owing to some relaxation from coronavirus-related restrictions.
Bed Bath & Beyond to Reopen Stores & Expand Pickup Options
by Zacks Equity Research
Bed Bath & Beyond (BBBY) intends to reopen few stores by May 22, in sync with the current regulations. Further, it is on track to expand pickup services to 200 more stores.
Do Options Traders Know Something About Bed Bath & Beyond (BBBY) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Bed Bath & Beyond (BBBY) stock based on the movements in the options market lately.
Bed Bath & Beyond (BBBY) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
Bed Bath & Beyond (BBBY) reports solid Q4 results, despite sluggishness during the holiday season and higher clearance activities. Management holds back FY20 view due to CVOID-19 impacts.
Bed Bath & Beyond (BBBY) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Bed Bath & Beyond (BBBY) delivered earnings and revenue surprises of 80.95% and 0.49%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?
Big Week of Q1 Earnings Coming Up
by Mark Vickery
Starting with the big banks and moving to companies working of a vaccine for COVID-19, we'll hope for the best and expect the worst.
Q1 Earnings in Focus
by Zacks Equity Research
Q1 Earnings in Focus
Here's How Bed Bath & Beyond (BBBY) Looks Ahead of Q4 Earnings
by Zacks Equity Research
Bed Bath & Beyond (BBBY) is likely to have witnessed a soft top line, lower gross margins and higher SG&A expense in fourth-quarter fiscal 2019, due to soft traffic trends and challenges in execution.
Earnings Preview: Bed Bath & Beyond (BBBY) Q4 Earnings Expected to Decline
by Zacks Equity Research
Bed Bath & Beyond (BBBY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bed Bath & Beyond (BBBY) Takes Action on Coronavirus Concerns
by Zacks Equity Research
Bed Bath & Beyond (BBBY) is keen on safeguarding its finances through drawings on credit facilities and employee furloughs, among others, as coronavirus continues to wreak havoc.
Coronavirus Dispirits Consumers: More Pandemic Doom Ahead?
by Sumit Singh
Market pundits predict a steeper fall in consumer sentiment next month, if the spread of virus is not contained that has already taken a toll on employment and household income.
Is Coronavirus Putting Miscellaneous Retail Industry in Peril?
by Sumit Singh
The coronavirus outbreak has been leading to supply-chain bottlenecks, slowdown in production activities and reduced demand for several commodities.
Bed Bath & Beyond to Close More Stores Amid Coronavirus Scare
by Zacks Equity Research
Bed Bath & Beyond (BBBY) will close all retail stores in the United States and Canada, apart from buybuy BABY and Harmon stores, to contain the spread of COVID-19.